ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

ClinicalTrials.gov ID: NCT05985915

Public ClinicalTrials.gov record NCT05985915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjögren's Syndrome

Study identification

NCT ID
NCT05985915
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
612 participants

Conditions and interventions

Interventions

  • Ianalumab (VAY736) Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 26, 2023
Primary completion
Apr 21, 2033
Completion
Apr 21, 2033
Last update posted
Apr 28, 2026

2023 – 2033

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Providence Medical Foundation Fullerton California 92835
Advanced Medical Research La Palma California 90623
Medvin Clinical Research Van Nuys California 91405
Bay Area Arthritis And Osteoporosis Brandon Florida 33511
GNP Research Cooper City Florida 33024
Sarasota Arthritis Res Ctr Sarasota Florida 34239
West Broward Rheumatology Associates Inc Tamarac Florida 33321
Augusta University Georgia Augusta Georgia 30912
North GA Rheumatology Group PC Suwanee Georgia 30024
Clin Invest Specialists Inc Orland Park Illinois 60467
University of Kansas Hospital Kansas City Kansas 66160
Ochsner Health System Baton Rouge Louisiana 70809
The John Hopkins Jerome L Greene Sjogren Baltimore Maryland 21224
Tufts School of Dental Medicine Boston Massachusetts 02111
Arthritis Osteoporosis Assoc of NM Las Cruces New Mexico 88011
Winthrop University Hospital Mineola New York 11501
St Lawrence Health System Potsdam New York 13676
Arthritis and Osteoporosis Charlotte North Carolina 28202
On Site Clinical Solutions Llc Charlotte North Carolina 28202
Carolina Arthritis Associates Wilmington North Carolina 28401
STAT Research Inc Dayton Ohio 45402
RAO Research LLC Oklahoma City Oklahoma 73116
Altoona Center for Clin Res Duncansville Pennsylvania 16635
West Tennessee Research Institute Jackson Tennessee 38305
Shelby Research LLC Memphis Tennessee 38119
Precision Comprehensive Research Colleyville Texas 76034
Baylor College Of Medicine Houston Texas 77030
Prolato Clinical Research Center Houston Texas 77054
Houston Rheumatology and Arthrit Katy Texas 77494
First Outpatient Research Unit San Antonio Texas 78229
Advanced Rheumatology of Houston Spring Texas 77382
Arthritis Northwest PLLC Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 165 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05985915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05985915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →